Insmed (INSM) PT Raised to $172 at Guggenheim, 'continue to see it as a Top Pick'
Tweet Send to a Friend
(Updated - September 8, 2025 7:22 AM EDT)
Guggenheim analyst Vamil Divan raised the price target on Insmed (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Vamil Divan raised the price target on Insmed (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
